§ 12-6C-03.2. Inspection of sterile drug products; report.

MD Health Occ Code § 12-6C-03.2 (2019) (N/A)
Copy with citation
Copy as parenthetical citation

(a)    Notwithstanding any other provision of this subtitle, a wholesale distributor applicant or permit holder that prepares sterile drug products shall submit to the Board a report of an inspection conducted by the U.S. Food and Drug Administration or a Board designee:

(1)    At the time of application; and

(2)    On renewal.

(b)    The inspection report required under subsection (a) of this section shall:

(1)    Be conducted within 1 year before the date of application or renewal; and

(2)    Demonstrate compliance with applicable federal good manufacturing practice standards.

(c)    An applicant or permit holder is responsible for obtaining an inspection to meet the requirements of this section.